Sclerotherapy: a bloodless approach in treatment of pyogenic granuloma in children (original) (raw)
Related papers
Pyogenic Granuloma - A Simple Treatment Approach with Sclerotherapy
2021
Pyogenic granuloma (PG) is a benign exophytic vascular tumor, which is actually a reactive inflammatory mass of blood vessels with few fibroblasts within the mucosa or skin, was first reported by Hullihen in 1844. Variety of treatment options such as surgical excision, laser treatment, electrodessication, chemical cautery, cryosurgery, intralesional steroid injection etc. are available, but many a times, recurrence has also been reported. Sclerotherapy is defined as the "targeted elimination of small vessels, varicose veins and vascular anomalies by the injection of a "sclerosant". It offers an alternative to conventional methods like surgery, lasers, radio frequency ablation and electrodesiccation procedure with success and less chance of recurrences. Herein, we present a case of 22 years old female with a clinical diagnosis of PG, treated with intralesional 0.2 ml of 3% sodium tetradecyl sulfate (STS). The lesion healed completely at the patient's 3 rd visit and recurrence was not reported till the patient was followed up for one year.
Treatment of Pyogenic Granuloma with a Sclerosing Agent
Dermatologic Surgery, 2001
background. Pyogenic granulomas have been treated by cryosurgery, curettage, electrodesiccation, chemical cauterization, and laser surgery. The therapeutic effects of these conservative treatments are limited, however. objective. In this study, the efficacy of a sclerosing agent (monoethanolamine oleate) was evaluated for the treatment of pyogenic granuloma. methods. Pyogenic granuloma was treated by local injection of the monoethanolamine oleate solution in nine patients who were from 1 to 57 years of age (median 18 years). The treatment effect was determined by physical examination. results. All lesions were removed completely with no recurrence, and scars were inconspicuous in all cases. Complications occurred in only one patient who complained of pain due to an avoidable injection of excess solution. conclusion. Sclerotherapy with monoethanolamine oleate is effective in the treatment of pyogenic granuloma and offers an alternative to conventional methods in cases for which conservative treatment is preferable.
Efficacy of sclerotherapy with sodium tetradecyl sulphate in the treatment of pyogenic granuloma
Journal of Pakistan Association of Dermatology, 2018
Objective To determine the efficacy of sclerotherapy in treating pyogenic granuloma. Methods The present study was conducted at outpatient Department Dermatology, Unit I, Mayo Hospital, Lahore. 35 patients were enrolled and were injected with 0.1ml of 3% sodium tetradecyl sulfate with the help of an insulin syringe, without local anesthesia, till the point of blanching. Patient was called weekly for two weeks for follow up to see clearance of the lesion and then after 3 months to see any recurrence using a caliper. Results The mean age of the patients was 28.48±11.64 years. 42.9% patients were males and 57.1% patients were females. Complete clearance of lesion was found in 30 (85.7%) patients whereas 2 (5.7%) patients showed no reduction. Conclusion Sclerotherapy is an effective procedure for the treatment of pyogenic granuloma patients.
Resolution of recalcitrant pyogenic granuloma with laser, corticosteroid, and timolol therapy
Dermatology online journal
A pyogenic granuloma (PG) is a rapidly growing benign vascular tumor that can be found on the skin or subcutaneous tissue. While some pyogenic granulomas may resolve spontaneously, most have a tendency to bleed easily and require treatment. Current therapeutic modalities include topical imiquimod, cryotherapy, electrodessication, curettage, excision, laser therapy, sclerotherapy, and microembolization. We report a recalcitrant case of chronic pyogenic granuloma occurring on the scalp of a healthy young male which was unresponsive to conventional surgical and non-surgical modalities. Ultimately, aggressive laser therapy, intralesional triamcinolone acetonide injections, and topical timolol application led to complete resolution and healing.
Indian Journal of Otolaryngology and Head & Neck Surgery, 2020
Sclerotherapy is a targeted elimination of small vessels, varicose veins, and vascular anomalies by the injection of a sclerosant. Sclerotherapy aims to damage the vessel wall and transform it into fibrous tissue. The present study was conducted to evaluate the efficacy of a sclerosing agent 3% polidocanol in the treatment of vascular lesions and pyogenic granuloma. The solution was injected intralesionally at multiple sites and was repeated after an interval of 2 weeks. The treatment effect was determined by clinical examination. Sclerotherapy with 3% polidocanol is effective in the treatment of vascular lesions and pyogenic granuloma. This treatment modality offers an alternative to conventional methods such as surgical excision, laser therapy, cryotherapy, steroid therapy, etc., in cases where conservative treatment is preferable. The advantage is that it causes minimal discomfort, negligible blood loss, less cumbersome, and above all is economical. There is no requirement of local anesthesia or postoperative dressings or any specific care. The patient can resume his daily activities immediately.
Cryotherapy in the treatment of pyogenic granuloma
Journal of The European Academy of Dermatology and Venereology, 2006
Background Pyogenic granuloma is a benign, acquired, proliferative vascular lesion of the skin and mucous membranes. Many different treatments have been used for pyogenic granuloma with variable success rates.Objectives To evaluate the efficacy of cryotherapy in the treatment of pyogenic granuloma.Methods In a prospective observational study, 135 patients with pyogenic granuloma were treated with cryotherapy using liquid nitrogen. The patients were followed up every 3 weeks until 3 months after disappearance of the lesion.Results Complete resolution of the pyogenic granuloma was achieved in all patients after a mean of 1.58 treatments (range, 1–4 treatments). At the end of follow-up period, there was a flat imperceptible scar, smaller than the treated lesion, in 16 patients (11.8%). A hypertrophic scar, 3 mm in diameter, was observed in one patient. Hypopigmentation was observed in seven patients (5.1%). No other complication or side-effect was recorded in the study.Conclusions We believe that pyogenic granuloma can be treated simply and effectively with cryotherapy.
Pyogenic granuloma in children: Treatment with topical imiquimod
Australasian Journal of Dermatology, 2007
We report the successful treatment of five children with facial pyogenic granuloma using topical imiquimod 5% cream. In all cases, resolution of the lesions was achieved within 2-4 weeks. Local erythema and scaling, consistent with a typical imiquimod response, was the most commonly observed side effect. No systemic complications were observed in any of the patients. There has been no recurrence of any of the lesions to date. Small mildly erythematous or hypopigmented macules remain at this stage of follow up.